FCPM III SERVICES B.V. Q1 2025 Filing

Filed May 15, 2025

Portfolio Value

$413.7B

Holdings

7

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (7 positions)

#StockSharesValue% PortfolioType
1
NAMSNEWAMSTERDAM PHARMA COMPANY
10,935,310$223.8B54.11%
2
DYNDYNE THERAPEUTICS INC
5,462,846$57.1B13.81%
3
ENGNENGENE HOLDINGS INC
9,632,561$43.2B10.43%
4
REPLREPLIMUNE GROUP INC
3,909,696$38.1B9.21%
5
BCYCBICYCLE THERAPEUTICS PLC
3,452,330$29.3B7.08%
6
CATBUSDASTRIA THERAPEUTICS INC
3,822,537$20.4B4.93%
7
ENGNWENGENE HOLDINGS INC
2,878,148$1.7B0.42%